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TO THE EDITOR
Progressive macular hypomelanosis
(PMH) is a skin disorder characterized
by ill defined, nummular, symmetri-
cally localized, hypopigmented ma-
cules on sebum-rich areas of the skin
(Figure 1) (Relyveld et al., 2007).
In 2004 Westerhof et al., 2004
showed Propionibacterium acnes
bacteria in red follicular fluorescent
lesional skin of PMH patients who
could not be cultured from adjacent
normal skin. P. acnes has an important
role in the pathogenesis of acne.
However, acne does not seem to
predispose for PMH and patients with
PMH do not have acne more often than
the general population.
The purpose of this study was to
identify, through amplified fragment
length polymorphism (AFLP), 16S
rRNA gene sequencing and biochem-
ical characterization, the bacterial spe-
cies that is related to PMH. We
hypothesized that this species would
be different from the bacterial species
causing acne, and that it cannot be
differentiated from the species that
causes acne by conventional culture
and biochemical methods. Identifica-
tion of the bacterial species that causes
PMH might lead to better understand-
ing of the disease and better treatment
modalities.
Amplified Fragment Length Poly-
morphism is a genetic mapping techni-
que that generates a unique fingerprint
of a particular genome. The AFLP
patterns for Propionibacterium can be
divided in three windows of similarity
(Mohammadi et al., 2005). The first
window, between 55 and 100%, de-
fines strains of the same species; the
second window, between 30 and 55%,
defines strains of related species,
possibly different subspecies; the third
window, below 30% defines strains
of different species (Savelkoul et al.,
1999).
16S DNA sequencing is the golden
standard for taxonomic species identi-
fication; the comparison of the 16S
rRNA gene sequences allows differen-
tiation between organisms at the genus
level in addition to classification of
strains at the species and subspecies
level (Clarridge, 2004).
Fourteen patients with PMH and
10 patients with acne were included
in this prospective study. The Declara-
tion of Helsinki protocols were followed
and the study was approved by the
medical ethical commission of
the Academic Medical Center in
Amsterdam, The Netherlands. All patients
provided written, informed consent
before entering the study. Patients
under the age of 18 needed parental
consent to be included.
The diagnosis of PMH was based
on the previously mentioned clinical
signs and negative KOH tests.
Patients with any form of acne on the
trunk (mild, moderate, severe) and
without hypopigmented lesions on
the skin were included in the acne
group.
Figure 1. 28-Year-old PMH patient.
Abbreviations: AFLP, amplified fragment length polymorphism; PMH, progressive macular
hypomelanosis
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Figure 2. AFLP results. (a) UPGMA dendrogram derived from the AFLP patterns of 25 isolates of all 24 acne and PMH patients (from one acne patient two
different bacterial isolates were obtained: TY 3571/TY 3572). Reference strains Propionibacterium acnes, P. granulosum, P. avidum, and P. propionicus were
included in the analysis. The analysis was performed between 200 and 500bp. Three different DNA groups are indicated in the dendrogram by the numbers 1,2,
and 3 (and by the colored lines). In addition, three windows of similarity were determined. Window I (eight acne patients and six PMH patients): between 55 and
100% homology suggests the same species; window II (two acne patients): between 30 and 55% homology suggests related species, possibly subspecies;
window III (eight PMH patients): o30% homology indicates different species, forming a clear distinct DNA group based on low-percentage homology.
(b) Intrapatient strain variation AFLP results: UPGMA dendrogram derived from 59 isolates of three acne patients and three PMH patients. The colors represent
the strains per patient. Yellow, pink, and green represent the acne patients; blue, purple, and orange represent the PMH patients. AFLP, amplified fragment
length polymorphism; PMH, progressive macular hypomelanosis; UPGMA, unweighted pair group method with arithmetic mean.
www.jidonline.org 1183
GN Relyveld et al.
Progressive Macular Hypomelanosis
Biopsies (2mm) were taken from a
red fluorescent hair follicle in lesional
skin from PMH patients and from a red
fluorescent papule in acne patients. The
biopsy specimens were swapped on
blood agar plates and transported under
anaerobic conditions for processing and
culturing. P. acnes (DSM 1897, ATCC
6919), P. granulosum (DSM 20700,
ATCC 25564), P. avidum (DSM 4901,
ATCC 25577) and P. propionicus (DSM
43307, ATCC 14157) were included as
reference strains.
AFLP was performed for molecular
characterization of the bacterial strains
from all acne and PMH patients. This
resulted in three groups (Figure 2a):
group 1 comprised strains isolated from
eight acne patients and six PMH pa-
tients. The isolates showed a similarity
between 55 and 100% with the refer-
ence P. acnes strain. Group 2 com-
prised strains from two acne patients,
showing a similarity level between 30
and 55%. Isolates from group 3 com-
prised strains isolated solely from
PMH patients (n¼8). For these strains
a similarity level o30% with the
reference P. acnes strain was observed.
All clinical strains showed a similarity
level of o30% when compared with
P. avidum, P. granulosum and P.
propionicus.
To exclude the presence of a mixture
of different species in one patient, we
subjected 29 independent bacterial
isolates from primary skin culture of
three acne patients to the AFLP finger-
printing technique. The strains were
identical per patient and showed a
similarity 430% with the reference
strain P. acnes, and fell into DNA group
1/2. Thirty independent primary colo-
nies isolated from the skin of three
PMH patients were also examined.
Again the strains were identical per
patient and isolates (20) of two patients
showed a similarity level o30% with
the P. acnes strain, comparable with
bacteria in DNA group 3. The 10
bacterial isolates from the other PMH
patient showed a similarity between
55 and 100% with the reference strain
P. acnes, comparable with bacteria in
group 1 (Figure 2b).
To confirm our AFLP findings, 16S
rRNA gene sequencing was performed
on two isolates (from one acne and one
PMH patient) from DNA group 1, 1
(from one acne patient) from group 2
and 3 (from three PMH patients)
from group 3. Comparison of the
various strains with P. acnes reference
strain ATCC 6919 showed one
nucleotide difference at position 827
with the isolates of group 2, and 1
nucleotide difference at position 1243
with the isolates of group 3. One isolate
(TY 3585) of DNA group 3 had
an additional nucleotide difference
at position 712 besides the one at
position 1243.
To determine whether our findings at
the DNA level correlated with bio-
chemical characteristics, six isolates,
two out of each DNA group were
analyzed with the rapid ID 32A multit-
est identification system. Isolates from
group 1 and 2 were identified as
P. acnes with a certainty of 99.9%.
The isolates from group 3 were labeled
with an ‘‘un-acceptable profile’’. Sensi-
tivity and resistance analysis of all
strains were similar and typical for
P. acnes.
We showed by AFLP characteriza-
tion that bacteria cultured from 8 out of
14 PMH patients were substantially
different from the P. acnes bacteria
seen in acne. Interestingly, these bac-
teria were not detected in any of the
acne patients. 16S rRNA gene sequen-
cing and biochemical tests showed only
minor differences between the groups
of bacteria. This suggests that we
might be dealing with a bacterium of
the genus Propionibacterium, but of a
yet undefined species. Strikingly our
AFLP and 16S rRNA gene sequencing
results are comparable with previous
findings of Mohammadi et al., 2005
and McDowell et al., 2005 who de-
scribed three different types of P. acnes
strains when studying the source of
bacterial contamination of platelet con-
centrates.
This study shows that conventional
identification methods are not sufficient
to distinguish some species or subspe-
cies of specific genera that may have an
important role in the pathogenesis of
diseases. Further research is necessary
to substantiate the importance of
the role of this, to our knowledge
previously unreported Propionibacter-
ium species in PMH.
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